343 related articles for article (PubMed ID: 35697438)
1. PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial.
Euden J; Thomas-Jones E; Aston S; Brookes-Howell L; Carman J; Carrol E; Gilbert S; Howard P; Hood K; Inada-Kim M; Llewelyn M; McGill F; Milosevic S; Niessen LW; Nsutebu E; Pallmann P; Schmidt P; Taylor-Robinson D; Welters I; Todd S; French N;
BMJ Open; 2022 Jun; 12(6):e063424. PubMed ID: 35697438
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
3. Biomarker-guided duration of Antibiotic Treatment in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trial.
Waldron CA; Thomas-Jones E; Bernatoniene J; Brookes-Howell L; Faust SN; Harris D; Hinds L; Hood K; Huang C; Mateus C; Pallmann P; Patel S; Paulus S; Peak M; Powell C; Preston J; Carrol ED
BMJ Open; 2022 Jan; 12(1):e047490. PubMed ID: 35078830
[TBL] [Abstract][Full Text] [Related]
4. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial.
Huang L; Wang J; Gu X; Sheng W; Wang Y; Cao B
BMJ Open; 2021 Aug; 11(8):e049515. PubMed ID: 34353802
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
[TBL] [Abstract][Full Text] [Related]
8. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
9. Assessment of the impact of a new sequential approach to antimicrobial use in young febrile children in the emergency department (DIAFEVERCHILD): a French prospective multicentric controlled, open, cluster-randomised, parallel-group study protocol.
Hubert G; Launay E; Feildel Fournial C; Chauvire-Drouard A; Lorton F; Tavernier E; Giraudeau B; Gras Le Guen C
BMJ Open; 2020 Aug; 10(8):e034828. PubMed ID: 32792425
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
11. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
[TBL] [Abstract][Full Text] [Related]
12. PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial.
Bessat C; Bingisser R; Schwendinger M; Bulaty T; Fournier Y; Della Santa V; Pfeil M; Schwab D; Leuppi JD; Geigy N; Steuer S; Roos F; Christ M; Sirova A; Espejo T; Riedel H; Atzl A; Napieralski F; Marti J; Cisco G; Foley RA; Schindler M; Hartley MA; Fayet A; Garcia E; Locatelli I; Albrich WC; Hugli O; Boillat-Blanco N;
Trials; 2024 Jan; 25(1):86. PubMed ID: 38273319
[TBL] [Abstract][Full Text] [Related]
13. Prehospital early warning scores for adults with suspected sepsis: the PHEWS observational cohort and decision-analytic modelling study.
Goodacre S; Sutton L; Ennis K; Thomas B; Hawksworth O; Iftikhar K; Croft SJ; Fuller G; Waterhouse S; Hind D; Stevenson M; Bradburn MJ; Smyth M; Perkins GD; Millins M; Rosser A; Dickson J; Wilson M
Health Technol Assess; 2024 Mar; 28(16):1-93. PubMed ID: 38551135
[TBL] [Abstract][Full Text] [Related]
14. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial.
Siriwardena AK; Jegatheeswaran S; Mason JM; Baltatzis M; Chan A; Sheen AJ; O'Reilly D; Jamdar S; Deshpande R; de Liguori Carino N; Satyadas T; Qamruddin A; Hayden K; Parker MJ; Butler J; Rajai A; McIntyre B
Trials; 2019 Jul; 20(1):463. PubMed ID: 31358032
[TBL] [Abstract][Full Text] [Related]
15. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
[TBL] [Abstract][Full Text] [Related]
16. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
[TBL] [Abstract][Full Text] [Related]
19. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns).
Stocker M; van Herk W; El Helou S; Dutta S; Fontana MS; Schuerman FABA; van den Tooren-de Groot RK; Wieringa JW; Janota J; van der Meer-Kappelle LH; Moonen R; Sie SD; de Vries E; Donker AE; Zimmerman U; Schlapbach LJ; de Mol AC; Hoffman-Haringsma A; Roy M; Tomaske M; Kornelisse RF; van Gijsel J; Visser EG; Willemsen SP; van Rossum AMC;
Lancet; 2017 Aug; 390(10097):871-881. PubMed ID: 28711318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
